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A B S T R A C T
Fifty consecutive and consenting epilepsy patients from the Zagreb Epilepsy Center were examined for the presence of
depressive symptoms using the Beck Depression Inventory (BDI). This questionnaire has been previously validated for
use in the Croatian population. Mean age of the patients was 30.8±13.5 years, 60.4% were females. Majority of them were
employed (72.9%) and single (62.5%), and 35.4% had a university degree. Most of them had complex partial seizures
(n=40, 80%), and 6 (12%) were diagnosed with idiopathic generalized epilepsy. Assessment with the BDI showed that
33.3% of patients had recent depressive symptoms: 6.3% hadmild depressive symptoms, 8.4%moderate and 18.6% severe
depressive symptoms. Three patients (6.4%) attempted suicide in the past, two of them had current suicidal ideation, and
all of them were severely depressed. This is the first and preliminary study assessing mood dysfunction in epilepsy pa-
tients in Croatia. Increased prevalence of depression in epilepsy patients suggests specific approach and need for early
treatment.
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Introduction
Epilepsy is a chronic disorder that has complex rela-
tions with social, vocational and psychological function-
ing. Recent studies showed that frequency of mood disor-
ders in patients with epilepsy is increased and include
depression, anxiety and psychosis.
In the patients with pharmacoresistant epilepsy prev-
alence of depression ranges between 20–55% and it is
lower, but still increased at about 8–10%, in the patients
with fully controlled seizures1,2. In general population
the prevalence of depression is 2–4%3. Current data indi-
cate that mood dysfunction affects patients’ perspective
of quality of life4. In a patient sample from a video/EEG
seizure monitoring unit, Boylan et al. found that 50% of
epilepsy patients had depressive symptoms and only 17%
of them were currently treated with an antidepressant.
Mendez et al.6 used the Hamilton Depression Rating
Scale in 175 consecutive patients in an outpatient epi-
lepsy clinic, reporting that 55% met criteria for depres-
sion. In a community-based study using the Hospital
Anxiety and Depression Scale, Jacoby et al.1 observed
that 21% of 168 patients with medication refractory sei-
zures were depressed. O’Donoghue et al.8 used the same
scale to demonstrate that in 155 patients from two large
primary care practices in the United Kingdom, 33% with
recurrent seizures and 6% of those in remission had
symptoms of depression. Although these studies have
methodological variabilities, prevalence of depression is
considerably increased in patients with pharmacoresis-
tant epilepsy than in general population.
However, reports of the prevalence of depressive sym-
ptoms in the patients with epilepsy have been mostly re-
ported from developed countries. There are only few
studies performed in developing countries that include
Croatia. These studies show that prevalence of depres-
sive symptoms appears to be in the similar range. In a
hospital based cross-sectional study in four major cities
in China8 and the population study in the Nigeria9, prev-
alence of depressive symptoms was 38.6%, and 30.8%, re-
spectively. Both studies used the same, Hospital Anxiety
and Depression (HAD) scale. Highest prevalence of de-
ressive symptoms in patients with epilepsy (84%) was
reported in Togo and Benin (West Africa) using a signifi-
cant modification of the Goldberg’s anxiety and depres-
sion scale10.
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A number of recent studies assessing self-reported
quality of life in epilepsy patients showed stronger asso-
ciation with depression, than with seizure factors, in-
cluding seizure frequency11–16. Gilliam et al. suggested
that depression in epilepsy patients is the strongest pre-
dictor of multiple measures of health outcomes. This
group found that depression is more closely related to the
overall function and well-being of the patient, than it is
with seizure frequency, severity of seizures, IQ or em-
ployment. Similar findings, that depression was the sin-
gle strongest predictor for each Health-Related Quality
of Life domains (HRQOL), were observed by Lehrner et
al. in 56 consecutive patients with temporal lobe epilepsy
(TLE). The significant association of depression with
HRQOL persisted after controlling for seizure frequency,
seizure severity, and other psychosocial variables. Re-
ports also suggest that people with psychiatric depres-
sion and normal neurological examination are at in-
creased risk for developing epilepsy17. Hesdorffer et al.
showed that attempted suicide should be considered as a
predictor for unprovoked seizures in a survey from the
Icelandic general practice database17. This risk remained
when averaged for age, gender, length of medical fol-
low-up, and medical therapies for depression. Some au-
thors also argued that antiepileptic drugs can in some in-
dividuals cause or aggravate depressive symptoms15.
Specific screening and diagnostic tests have been de-
veloped for the evaluation of depression in epilepsy. One
well validated and reliable instrument for assessment of
depressive symptoms in epilepsy patients is the Beck De-
pression Inventory (BDI)18. Jones et al. showed that this
test reliably detects depressive symptoms and possibly
substitute for larger psychiatric assessment19.
In this study we determined prevalence of depressive
symptoms in epilepsy patients in Croatia. This is the first
and preliminary study to examine prevalence of mood
dysfunction in epilepsy patients in Croatia.
Patients and Methods
We examined 50 consecutive and consenting epilepsy
patients at the Zagreb Epilepsy Center during 2005.
Clinic at the Zagreb Epilepsy Center is visited by approx-
imately 500 epilepsy patients annually, and about 25–
30% of them are newly diagnosed with epilepsy. The Cen-
ter is fully equipped with standard EEG machines and
accommodates a one bed long term video/EEG monitor-
ing unit. The patients were also referred to the Center by
general practitioners or neurologists from other hospi-
tals in Croatia.
Clinical data for patients included age, gender, seizure
factors (seizure frequency and type, epilepsy duration,
time to initial diagnosis and epileptic region lateraliza-
tion), education, employment and marital status. These
variables were collected in the clinic and the epilepsy
evaluation was done on standard digital EEG recordings.
Seizure frequency was self-reported by the patients and
then averaged for each month for the previous six
months. All subjects were evaluated using the BDI. This
questionnaire has been widely used for evaluation of re-
cent (during past two weeks) depression symptoms in
persons with epilepsy. This test has been previously vali-
dated for use in the Croatian population. The BDI re-
quires a self-rating from 0–3 on 21 items; a cumulative
total from the addition of individual scores is recorded.
Scores of 11 to 15 are indicative of mild, 16–23 of moder-
ate, and 24 or greater of severe depression. The question-
naire was given to the patients by an epileptologist (HH)
before further clinical evaluation. This epileptologist ex-
plained to patients a completion of the questionnaire in
great detail. Each patient also signed the consent form.
After completion, the answers were immediately entered
into our data base. Patients with the BDI scores indica-
tive of clinical significant depression and patients with
previous or current suicidal ideation or suicidal attempt
have been referred to a psychiatrist. Statistical analysis
was performed using the SPSS (Chicago, IL, v.11.0) pro-
gram.
Results
Mean age of the patients was 30.8±13.5 years. Major-
ity of them were females (60.4%), employed (72.9%), sin-
gle (62.5%) and 35.4% of subjects had a university degree
(Table 1). Most of the patients had complex partial sei-
zures (n= 40, 80%), and 6 (12%) were diagnosed with id-
iopathic generalized epilepsy. For four patients the type
of epilepsy was not defined. The mean self-reported monthly
seizure frequency rate, adjusted for the previous six
months, was 2.0±3.4. At the time of their office visit
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TABLE 1
DEMOGRAPHIC AND CLINICAL VARIABLES FOR
EPILEPSY PATIENTS
Age (y) 30.8±13.5
Gender (M/F, %) 39.6/60.4
Employed (Y/N, %) 72.9/21.1






Seizure frequency (average for the past
6 months)
2.0±3.4
Epilepsy duration (y) 10.8±8.94







Total BDI score >11
Depressive symptoms:
Mild (total BDI 11–15)
Moderate (total BDI 16–24)





Past suicide attempt (n=3) 6.4%
M – male, F – female, Y – yes, N – no, y – years, IGE – idiopathic
generalized epilepsy, CPS – complex partial seizures, AED – an-
tiepileptic drug, BDI – Beck Depression Inventory
31.3% were recently diagnosed patients with epilepsy,
45.8% of all subjects received AED monotherapy, 18.8%
had two, and 4.2% had three antiepileptic drugs (AED).
Assessment with the BDI showed that 33.3% of pa-
tients had recent depressive symptoms: 6.3% had mild
depressive symptoms, 8.4% moderate and 18.6% had se-
vere depressive symptoms (Figure 1). Three (6.4%) pa-
tients attempted suicide in the past, two of them had cur-
rent suicidal ideation, and all three were with severe
symptoms of depression.
Discussion
This is the first study assessing mood dysfunction in
epilepsy patients in Croatia. We confirmed an increased
prevalence of depression in epilepsy patients and showed
that every third patient had recent depressive symptoms.
There were more subjects with clinically significant de-
pressive symptoms than with mild depression. Addi-
tionally we found that 6.4% of our patients attempted
suicide in the past and endorsed current depression.
Our study consisted of predominantly younger popu-
lation with an average socioeconomic background. Al-
most half of them were on AED monotherapy and had
complex partial seizures. Average duration of epilepsy
was a decade. Although studies suggest that only a com-
plete seizure freedom can improve quality of life, some of
them found that decreased quality of life is due to in-
creased seizure severity, epilepsy duration, patient age
and medication toxicity. Others observed that patients
with temporal lobe epilepsy have increased levels of de-
pression or suicidal ideation in the postictal state21. Ba-
ker et al.22 evaluated social factors and reported that
high seizure frequency and lower levels of knowledge
about epilepsy lead to depressive symptoms, lower self-
esteem and higher levels of social anxiety. In our study
33% patients had recent depressive symptoms. The ma-
jority of our depressed patients endorsed severe symp-
toms (18.6%).
Possible reasons for inadequate detection and treat-
ment include underestimation of the importance of the
impact of depression on quality of life, fear of seizure ex-
acerbation by antidepressants, and thoughts that antide-
pressants are ineffective in epilepsy patients. The rela-
tive importance of depression in epilepsy compared to
other variables such as seizure frequency and severity
has only recently been examined. Depression, and not so-
cial and vocational factors, appears to be a stronger pre-
dictor of quality of life than seizure frequency partial re-
duction in patients with active epilepsy. This has impor-
tant implications on treatment of patients with epilepsy.
Recognition of depression in patients with epilepsy is es-
sential to avoid complications directly resulting from se-
verity of depressive disorder, including worsening of the
seizure disorder. Thus, we suggest that screening for
mood dysfunction should be regularly done in epilepsy
clinics.
There are number of limitations of the current study.
In this study we included only patients from a tertiary
care center. These subjects might not be representative
epilepsy patients in general population. Seizure frequen-
cy was self-reported by the patients and their answers
might have bias due to stigma or unawareness of all their
seizures. We used BDI test and not the full psychiatric
evaluation to assess for depression and other psychiatric
comorbidities. Some symptoms, albeit minor, can poten-
tially be influenced by use of antiepileptic drugs. One
suggestion is to use the Neurological disorders depres-
sion inventory for epilepsy (NDDI-E)19 in future studies,
a test that evaluates symptoms of depression without in-
fluence from AED side effects.
Available evidence indicates that most patients with
epilepsy are not screened for depression, and a small pro-
portion of affected patients are subsequently treated.
The hesitance to screen and treat may be partially based
on the belief that antidepressant medications lower the
seizure threshold, despite the recent evidence not sup-
porting this assumption. Many questions including risk
factors and neurobiology of depression in epilepsy, its
chronicity, contributions to long-term disability and poor
health status, most effective treatments, and predictors
of refractoriness will need to be addressed before optimal
management strategies can be implemented to improve
the lives of persons with epilepsy. Our results strongly
suggest ethnic and cultural similarities in prevalence of
depression in epilepsy in developed and developing coun-
tries and importance of mood dysfunction in health out-
comes in epilepsy.
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Fig. 1. Prevalence and severity of depressive symptoms in patients
with epilepsy.
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PREVALENCIJA POREME]AJA RASPOLO@ENJA KOD BOLESNIKA S EPILEPSIJOM
U HRVATSKOJ
S A @ E T A K
U ovoj studiji je prikazano 50 konsekutivnih bolesnika s epilepsijom i njihova evaluacija u Centru za epilepsije »Zag-
reb« pojave simptoma depresije pomo}u Beck Depression Inventory (BDI). Svi bolesnici su dali svoju suglasnost za
sudjelovanje u studiji. Srednja dob bolesnika je bila 30.8±13.5 godina, 60.4% su bile `ene. Ve}ina bolesnika je bila
zaposlena (72.9%), izvan bra~ne zajednice (62.5%), a 35.4% ispitanika je imalo zavr{enu visoku stru~nu spremu. Ve}ina
ispitanika je imala kompleksne parcijalne napadaje (n=40, 80%), a 6 bolesnika (12%) je imalo idiopatsku generaliziranu
epilepsiju. Rezultati BDI studije su pokazali da je 33.3% ispitanika imalo recentne depresivne simptome, 6,3% blage,
8.4% umjerene te 18.6% te{ke depresivne simptome. Tri bolesnika (6.4%) su imala suicidalne namjere u pro{losti, dva
ispitanika su imala sada{nje suicidalne misli, a svo troje je i dalje imalo simptome te{ke depresije. Ovo je prva i prelimi-
narna studija koja je analizirala prevalenciju poreme}aja raspolo`enja kod bolesnika s epilepsijom u Hrvatskoj. Pove-
}ana prevalencija depresije u bolesnika s epilepsijom zahtjeva poseban pristup i potrebu za ranom dijagnozom i lije~e-
njem.
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